IMPACT OF GOLIMUMAB ON PHYSICAL FUNCTION AND EMPLOYABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS: 5-YEAR DATA FROM 3 PHASE III CLINICAL TRIALS

被引：0
|
作者：
Han, C. [1 ]
Keystone, E. [2 ]
Fleischmann, R. [3 ]
Smolen, J. [4 ,5 ]
Matteson, E. L. [6 ]
Emery, P. [7 ,8 ]
Genovese, M. [9 ]
Gathany, T. [1 ]
Hsia, E. C. [10 ,11 ]
机构：
[1] Johnson & Johnson Pharmaceut Serv LLC, Malvern, PA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Med Univ Vienna, Vienna, Austria
[5] Hietzing Hosp, Vienna, Austria
[6] Mayo Clin, Rochester, NY USA
[7] Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[8] Univ Leeds, Leeds, W Yorkshire, England
[9] Stanford Univ, Palo Alto, CA 94304 USA
[10] Janssen Res & Dev LLC, Spring House, PA USA
[11] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.2535
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0156
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [21] Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan
    Hirata, Akie
    Suenaga, Yasuo
    Miyamura, Tomoya
    Matsui, Toshihiro
    Tohma, Shigeto
    Suematsu, Eiichi
    Ohnaka, Keizo
    Takayanagi, Ryoichi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (04) : 828 - 835
  • [22] PATIENTS REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED WITH GOLIMUMAB: SUB-ANALYSIS OF ASIA POPULATION ENROLLED IN MULTICENTRE PHASE III CLINICAL TRIALS
    Genovese, M.
    Deodhar, A.
    Hsia, E.
    Hsu, B.
    Lin, Y. J.
    Han, C.
    VALUE IN HEALTH, 2012, 15 (07) : A674 - A674
  • [23] Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials
    Moots, Robert J.
    Sebba, Anthony
    Rigby, William
    Ostor, Andrew
    Porter-Brown, Benjamin
    Donaldson, Francis
    Dimonaco, Sophie
    Rubbert-Roth, Andrea
    van Vollenhoven, Ronald
    Genovese, Mark C.
    RHEUMATOLOGY, 2017, 56 (04) : 541 - 549
  • [24] Stable mental and physical disease course in a 5-year longitudinal study of patients with rheumatoid arthritis.
    Uhlig, T
    Smedstad, LM
    Kvien, TK
    Vaglum, P
    Moum, T
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S222 - S222
  • [25] Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial
    Genovese, Mark C.
    Pacheco-Tena, Cesar
    Covarrubias, Arturo
    Leon, Gustavo
    Mysler, Eduardo
    Keiserman, Mauro
    Valente, Robert M.
    Nash, Peter
    Abraham Simon-Campos, J.
    Box, Jane
    Legerton, Clarence W., III
    Nasonov, Evgeny
    Durez, Patrick
    Elegbe, Ayanbola
    Wong, Robert
    Li, Xiaohui
    Banerjee, Subhashis
    Alten, Rieke
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (08) : 1085 - 1092
  • [26] INTRAVENOUS GOLIMUMAB THERAPY IMPROVES HEMOGLOBIN, RESULTING IN REDUCED ANEMIA, IMPROVED PHYSICAL FUNCTION AND FATIGUE IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS: RESULTS FROM GO-FURTHER PHASE III CLINICAL TRIAL
    Han, C.
    Weinblatt, M. E.
    Westhovens, R.
    Kim, L.
    Hsia, E. C.
    Parenti, D.
    Kafka, S.
    Bingham, C. O., III
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 226 - 226
  • [27] INTEGRATED SAFETY DATA ANALYSIS ACROSS PHASE 3 CLINICAL STUDIES FOR INTRAVENOUS GOLIMUMAB IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Husni, M. E.
    Schwartzman, S.
    Deodhar, A.
    Kafka, S.
    Chakravarty, S. D.
    Hsia, E. C.
    Harrison, D. D.
    Leu, J. H.
    Zhou, Y.
    Lo, K. H.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 608 - 609
  • [28] Sustained improvement in physical function after etanercept treatment in patients with rheumatoid arthritis (3-year interim data).
    Kalden, JR
    Pedersen, R
    Yeh, P
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S532 - S532
  • [29] FATIGUE IS AN INDEPENDENT VARIABLE PREDICTING PHYSICAL FUNCTION AND DAS-28 REMISSION FOR PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH INTRAVENOUSLY ADMINISTERED GOLIMUMAB: RESULTS FROM A PHASE 3, PLACEBO CONTROLLED CLINICAL TRIAL
    Westhovens, R.
    Weinblatt, M. E.
    Han, C.
    Gathany, T.
    Kim, L.
    Mack, M.
    Lu, J.
    Baker, D.
    Mendelsohn, A.
    Bingham, C.
    VALUE IN HEALTH, 2012, 15 (04) : A42 - A42
  • [30] IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH GOLIMUMAB: SUB-ANALYSIS OF ASIAN PATIENTS ENROLLED IN PHASE-3 CLINICAL TRIALS
    Tsai, W. C.
    Mu, R.
    Suh, C. H.
    Furtner, D.
    Lo, K. H.
    Zhou, Y.
    Hsia, E. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 447 - 448
12345